Influx Healthtech Ltd., a leading CDMO (Contract Development and Manufacturing Organization) in the domains of nutraceuticals, cosmetics, veterinary feed supplements, homecare, and Ayurveda, recently hosted a successful investor meet at MCA, BKC (Mumbai). The event was held in anticipation of the company’s upcoming SME IPO and witnessed enthusiastic participation from a wide spectrum of investors and financial professionals.
The session began with a comprehensive company presentation by Dr. Munir A. Chandniwala, Chairman and Managing Director of Influx Healthtech Ltd. He outlined the company’s strong foundation, diversified portfolio, robust manufacturing capabilities, and long-standing client relationships. The presentation was followed by an engaging Q&A session, where investors actively interacted with the leadership, gaining deeper insight into the company’s vision, growth strategy, and future roadmap.
The investor meet received an overwhelming response, instilling strong confidence within the investment community. With its solid track record, regulatory-compliant infrastructure, and a future-focused product pipeline, Influx Healthtech Ltd. is poised to create significant value for stakeholders as it enters the next phase of its growth journey through the SME IPO.